Guard Therapeutics International Stock Net Income
| GUARD Stock | SEK 1.44 0.03 2.04% |
Fundamental analysis of Guard Therapeutics allows traders to better anticipate movements in Guard Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Guard |
Guard Therapeutics International Company Net Income Analysis
Guard Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Guard Therapeutics Net Income | (82.03 M) |
Most of Guard Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guard Therapeutics International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Guard Therapeutics International reported net income of (82.03 Million). This is 124.04% lower than that of the Biotechnology sector and 217.11% lower than that of the Health Care industry. The net income for all Sweden stocks is 114.37% higher than that of the company.
Guard Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guard Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guard Therapeutics could also be used in its relative valuation, which is a method of valuing Guard Therapeutics by comparing valuation metrics of similar companies.Guard Therapeutics is currently under evaluation in net income category among its peers.
Guard Fundamentals
| Return On Equity | -1.53 | |||
| Return On Asset | -0.75 | |||
| Current Valuation | 120.17 M | |||
| Shares Outstanding | 503.08 M | |||
| Shares Owned By Insiders | 30.30 % | |||
| Shares Owned By Institutions | 35.55 % | |||
| Price To Book | 2.97 X | |||
| EBITDA | (82.03 M) | |||
| Net Income | (82.03 M) | |||
| Cash And Equivalents | 188.6 M | |||
| Cash Per Share | 0.44 X | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 10.80 X | |||
| Book Value Per Share | 0.30 X | |||
| Cash Flow From Operations | (77.59 M) | |||
| Earnings Per Share | (0.34) X | |||
| Target Price | 2.55 | |||
| Number Of Employees | 10 | |||
| Beta | 1.55 | |||
| Market Capitalization | 624.87 M | |||
| Total Asset | 190.44 M | |||
| Net Asset | 190.44 M |
About Guard Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guard Therapeutics International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guard Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guard Therapeutics International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Guard Stock Analysis
When running Guard Therapeutics' price analysis, check to measure Guard Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guard Therapeutics is operating at the current time. Most of Guard Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guard Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guard Therapeutics' price. Additionally, you may evaluate how the addition of Guard Therapeutics to your portfolios can decrease your overall portfolio volatility.